Fund profile
Tickers
BBH
Fund manager
Total assets
$479.27 mm
Liabilities
$203.47 k
Net assets
$479.07 mm
Number of holdings
23.00
BBH stock data
23 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN AMGEN Inc. | 83.91 mm | 291.33 k shares | 17.52 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 51.15 mm | 125.70 k shares | 10.68 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 49.95 mm | 616.64 k shares | 10.43 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 39.91 mm | 45.44 k shares | 8.33 | Common equity | Long | USA |
MRNA Moderna Inc | 25.89 mm | 260.32 k shares | 5.40 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 25.02 mm | 108.14 k shares | 5.22 | Common equity | Long | USA |
BIIB Biogen Inc | 23.22 mm | 89.72 k shares | 4.85 | Common equity | Long | USA |
ICON PLC
|
21.04 mm | 74.35 k shares | 4.39 | Common equity | Long | Ireland |
ARGX Argen X SE | 17.71 mm | 46.55 k shares | 3.70 | Common equity | Long | Netherlands |
ILMN Illumina Inc | 17.56 mm | 126.13 k shares | 3.67 | Common equity | Long | USA |
BeiGene Ltd
|
15.03 mm | 83.32 k shares | 3.14 | Common equity | Long | Cayman Islands |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 13.04 mm | 135.26 k shares | 2.72 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 11.50 mm | 60.08 k shares | 2.40 | Common equity | Long | USA |
BNTX BioNTech SE | 10.65 mm | 100.87 k shares | 2.22 | Common equity | Long | Germany |
TECH Bio-Techne Corp | 10.36 mm | 134.21 k shares | 2.16 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 10.29 mm | 43.53 k shares | 2.15 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 10.19 mm | 137.74 k shares | 2.13 | Common equity | Long | USA |
QIAGEN NV
|
8.62 mm | 198.40 k shares | 1.80 | Common equity | Long | Netherlands |
INCY Incyte Corp. | 8.42 mm | 134.11 k shares | 1.76 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 7.75 mm | 80.41 k shares | 1.62 | Common equity | Long | USA |
RGEN Repligen Corp. | 7.65 mm | 42.52 k shares | 1.60 | Common equity | Long | USA |
NTRA Natera Inc | 6.06 mm | 96.74 k shares | 1.26 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
4.17 mm | 66.55 k shares | 0.87 | Common equity | Long | Switzerland |